These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14594342)

  • 1. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
    Fan J; Armitstead JA; Adams AG; Davis GA
    Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.
    Fetrow CW; Overlock T; Leff L
    J Clin Pharmacol; 1997 Aug; 37(8):751-7. PubMed ID: 9378848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of warfarin-associated coagulopathy: a physician survey.
    Wilson SE; Douketis JD; Crowther MA
    Chest; 2001 Dec; 120(6):1972-6. PubMed ID: 11742930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous vitamin K1 injections: dangerous prophylaxis.
    O'Reilly RA; Kearns P
    Arch Intern Med; 1995 Oct; 155(19):2127-8. PubMed ID: 7575074
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
    Raj G; Kumar R; McKinney WP
    Arch Intern Med; 1999 Dec 13-27; 159(22):2721-4. PubMed ID: 10597763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
    Shetty HG; Backhouse G; Bentley DP; Routledge PA
    Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to guidelines for the management of excessive warfarin anticoagulation.
    Devine EB; Hopefl AW; Wittkowsky AK
    J Thromb Thrombolysis; 2009 May; 27(4):379-84. PubMed ID: 18465088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review.
    Fugate SE; Nichols CM; Cudd LA
    Pharmacotherapy; 2004 Sep; 24(9):1213-20. PubMed ID: 15460182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
    Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
    Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
    Bian C; Qi X; Li L; Zhao J; Liu X
    Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.